Skip to content
buyModerate

ADAR1 Capital Management, LLC bought $1.8M of TENX

owner at TENAX THERAPEUTICS, INC.. 1,025,867 shares at an average of $1.77, traded Aug 20, 2026, filed Aug 24, 2026.

Conviction score
46
Value
$1.8M
1,025,867 shares
Holdings after
4,853,818
+27% from before
From 52-week low
+29%
low $1.38, close $1.78
From 52-week high
-90%
high $18.32, as of Aug 20, 2026

Score components

  • Role
    10% owner
    +12
  • Trade size
    $1.8M at market
    +25
  • Relative to holdings
    Holdings up 27%
    +6
  • Price context
    90% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

TENXOct 12, 2026 · close 1.83
Since filing Aug 24, 2026: -1.1%SPY +2.2% · excess -3.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001940272-26-000017, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 20, 2026POpen-market purchase
Common Stockindirect: See Footnote
+202,124$1.78$360k4,030,075Aug 24, 2026
Aug 21, 2026POpen-market purchase
Common Stockindirect: See Footnote
+716,369$1.77$1.3M4,746,444Aug 24, 2026
Aug 24, 2026POpen-market purchase
Common Stockindirect: See Footnote
+107,374$1.75$188k4,853,818Aug 24, 2026

Related signals

Other insiders at TENAX THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
50Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Declan Doogan
director
$102k
53,000 shares
+2331%
50Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Christopher Thomas Giordano
CEO
$20k
10,850 shares
+96%
47Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Thomas R Staab II
Chief Financial Officer
$11k
5,675 shares
+57%
63Notable
TENXbuy 4
TENAX THERAPEUTICS, INC.
ADAR1 Capital Management, LLC
owner
$1.6M
900,000 shares
+16%
63Notable
TENXbuy 3
TENAX THERAPEUTICS, INC.
ADAR1 Capital Management, LLC
owner
$1.4M
770,333 shares
+16%
37Weak
TENXbuy
TENAX THERAPEUTICS, INC.
Stuart Rich
Chief Medical Officer
$51k
5,000 shares
+200%
39Weak
TENXbuy 2
TENAX THERAPEUTICS, INC.
Stuart Rich
Chief Medical Officer
$46k
5,000 shares
+1880%
48Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
Christopher Thomas Giordano
CEO
$20k
2,605 shares
-
38Weak
TENXbuy 3
TENAX THERAPEUTICS, INC.
June Sherie Almenoff
director
$15k
1,993 shares
-
38Weak
TENXbuy 3
TENAX THERAPEUTICS, INC.
June Sherie Almenoff
director
$15k
1,993 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ADAR1 Capital Management, LLC bought $1.8M of TENX | InsiderTell